Table 1 Comparison of general patient information ([M(Q1, Q3)])
Group | All patients (n = 67) | Group A (n = 49) | Group B (n = 18) | P value |
|---|---|---|---|---|
Characteristics | ||||
Age [years, M (Q1, Q3)] | 44.0 (36.0,59.0) | 41.0 (36.0,57.0) | 46.0 (37.3,60.3) | 0.344 |
Sex | – | – | – | 0.255 |
Men | 41 (61.2%) | 28 (57.1%) | 13 (72.2%) | – |
Women | 26 (38.8%) | 21 (42.9%) | 5 (27.8%) | – |
Exposure to the Hubei epidemic area | 60 (89.6%) | 43 (87.8%) | 17 (94.4%) | 0.435 |
Incubation period (days) | 7 (4,10) | 7.0 (4.5,10) | 6.5 (4,10) | 0.664 |
Comorbidity | 15 (22.4%) | 12 (24.5%) | 3 (16.7%) | 0.503 |
Hypertension | 4 (6.0%) | 4 (8.2%) | 0 | – |
Diabetes | 4 (6.0%) | 2 (4.1%) | 2 (11.1%) | – |
Respiratory diseases | 1 (1.5%) | 1 (2.0%) | 0 | – |
Chronic liver disease | 3 (4.5%) | 3 (6.1%) | 0 | – |
Chronic kidney disease | 2 (3.0%) | 2 (4.1%) | 0 | – |
Malignancy | 2 (3.0%) | 2 (4.1%) | 0 | – |
Other diseases | 3 (4.5%) | 2 (4.1%) | 1 (5.6%) | – |